Anixa Biosciences (ANIX) Profit After Tax (2010 - 2026)

Anixa Biosciences (ANIX) has 17 years of Profit After Tax data on file, last reported at -$2.5 million in Q2 2026.

• Quarterly Profit After Tax rose 9.85% year-over-year to -$2.5 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was -$10.4 million (up 15.53% YoY) and the FY2025 annual result came in at -$11.0 million, up 13.15% from the prior year.
• Profit After Tax climbed to -$2.5 million in Q2 2026, from -$2.7 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of -$2.3 million in Q3 2025 to a low of -$3.9 million in Q1 2022.
• A 5-year average of -$2.9 million and a median of -$2.8 million in 2025 frame the typical range for Profit After Tax.
• Annual changes were most pronounced in 2022 — Profit After Tax slumped 73.79% — and 2023, when it surged 39.31%.
• Tracing ANIX's Profit After Tax over 5 years: stood at -$3.5 million in 2022, then climbed by 22.9% to -$2.7 million in 2023, then fell by 7.06% to -$2.9 million in 2024, then climbed by 6.56% to -$2.7 million in 2025, then climbed by 6.83% to -$2.5 million in 2026.
• The last three Profit After Tax figures came in at -$2.5 million (Q2 2026), -$2.7 million (Q4 2025), and -$2.3 million (Q3 2025), per Business Quant data.